AIP
NVCT icon

Ameritas Investment Partners’s Nuvectis Pharma NVCT Stock Holding History

Ameritas Investment Partners’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2K Hold
1,314
– – ﹤0.01% 2862
2025
Q4 		$9.92K Hold
1,314
– – ﹤0.01% 2909
2025
Q3 		$7.91K Hold
1,314
– – ﹤0.01% 2992
2025
Q2 		$9.82K Buy
+1,314
New +$11.9K ﹤0.01% 2988
2024
Q2 		– Sell
-566
Closed -$4.64K – 3199
2024
Q1 		$4.64K Hold
566
– – ﹤0.01% 2959
2023
Q4 		$4.72K Hold
566
– – ﹤0.01% 2976
2023
Q3 		$7.3K Hold
566
– – ﹤0.01% 2919
2023
Q2 		$9.04K Buy
+566
New +$9.04K ﹤0.01% 2938

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameritas Investment Partners's NVCT Position: Q1 2026 in Review

Ameritas Investment Partners held its Nuvectis Pharma (NVCT) position steady in Q1 2026 at 1,314 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2862.

Ameritas Investment Partners first reported a position in NVCT in Q2 2023 and has held it in 8 quarters since. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Ameritas Investment Partners held 1,314 shares of Nuvectis Pharma worth $10.2K as of Q1 2026.
  • Ameritas Investment Partners left its Nuvectis Pharma share count unchanged in Q1 2026.
  • Nuvectis Pharma made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2862 holding.
  • Ameritas Investment Partners first reported a position in Nuvectis Pharma in Q2 2023 and has held it in 8 quarters since.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.